Affiliations 

  • 1 From the Department of Medicine, Duke University, Durham, NC (T.K.L., L.P., V.H.C., Z.S., V.G.F., A.L.C.); Department of Cardiology, Gentofte University, Copenhagen, Denmark (T.K.L., N.E.B.); Department of Infectious Diseases, Charles Darwin University, Darwin, Northern Territory, Australia (S.Y.C.T.); Department of Cardiology, CHU Nancy-Brabois, Nancy, France (C.S.-S.); Department of Medicine, UT-Southwestern Medical Center, Dallas, TX (G.P.); Department of Cardiology, Maria Vittoria Hospital, Torino, Italy (E.C.); Department of Medicine, Wayne State University, Detroit, MI (L.A.); Faculté de Médecine de Marseille, Marseille, France (G.H.); Department of Cardiology, University of Barcelona, Spain (C.P.); Department of Cardiology, Institut Jantung Negara, Kuala Lumpur, Malaysia (S.T.); Department of Medicine, New York University (S.D.); Division of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, University of California, Los Angeles (A.S.B.); Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden (M.C.J.); Duke Clinical Research Institute, Durham, NC (V.H.C., V.G.F., A.L.C.); and Clinical Institute, Aalborg University, Aalborg, Denmark (N.E.B.)
  • 2 From the Department of Medicine, Duke University, Durham, NC (T.K.L., L.P., V.H.C., Z.S., V.G.F., A.L.C.); Department of Cardiology, Gentofte University, Copenhagen, Denmark (T.K.L., N.E.B.); Department of Infectious Diseases, Charles Darwin University, Darwin, Northern Territory, Australia (S.Y.C.T.); Department of Cardiology, CHU Nancy-Brabois, Nancy, France (C.S.-S.); Department of Medicine, UT-Southwestern Medical Center, Dallas, TX (G.P.); Department of Cardiology, Maria Vittoria Hospital, Torino, Italy (E.C.); Department of Medicine, Wayne State University, Detroit, MI (L.A.); Faculté de Médecine de Marseille, Marseille, France (G.H.); Department of Cardiology, University of Barcelona, Spain (C.P.); Department of Cardiology, Institut Jantung Negara, Kuala Lumpur, Malaysia (S.T.); Department of Medicine, New York University (S.D.); Division of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, University of California, Los Angeles (A.S.B.); Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden (M.C.J.); Duke Clinical Research Institute, Durham, NC (V.H.C., V.G.F., A.L.C.); and Clinical Institute, Aalborg University, Aalborg, Denmark (N.E.B.). annalisa.crowley@duke.edu
Circ Cardiovasc Imaging, 2015 Jul;8(7):e003397.
PMID: 26162783 DOI: 10.1161/CIRCIMAGING.114.003397

Abstract

Staphylococcus aureus left-sided native valve infective endocarditis (LNVIE) has higher complication and mortality rates compared with endocarditis from other pathogens. Whether echocardiographic variables can predict prognosis in S aureus LNVIE is unknown.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.